Pharmacokinetics of Levosimendan in Children With Acute Heart Failure

Trial Profile

Pharmacokinetics of Levosimendan in Children With Acute Heart Failure

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Sep 2017

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Acute heart failure; Chronic heart failure
  • Focus Pharmacokinetics
  • Acronyms LevoCorKids
  • Most Recent Events

    • 20 Apr 2017 Planned End Date changed from 1 Nov 2016 to 1 Nov 2018.
    • 14 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
    • 05 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top